Affinity Asset Advisors, LLC Options Holdings

Affinity Asset Advisors, LLC

  • $560 Million
  • Q4 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
PUT
$67.5 Million
750K
Q4 2024
New holding
AMGN
Amgen Inc

Healthcare
CALL
$7.82 Million
30K
Q4 2024
New holding
SAVA
Cassava Sciences Inc

Healthcare
PUT
$4.1 Million
1.74M
Q4 2024
Added 20.02%
GALT
Galectin Therapeutics Inc

Healthcare
PUT
$2.97 Million
2.49M
Q4 2024
Added 105.71%
IBRX
Immunity Bio, Inc.

Healthcare
PUT
$640,000
250K
Q4 2024
New holding
BMEA
Biomea Fusion, Inc.

Healthcare
PUT
$582,000
150K
Q4 2024
New holding
Soleno Therapeutics Inc
CALL
$0
200
Q4 2024
New holding
Neumora Therapeutics Inc.
CALL
$0
475K
Q4 2024
New holding
Mesoblast LTD
PUT
$0
839K
Q4 2024
New holding
Syros Pharmaceuticals Inc
PUT
$0
1.54M
Q4 2024
Added 24.87%

Summary

  • Portfolio
  • No. of Stocks 85
  • Current Value $560 Million
  • Prior Value $579 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 15 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email